{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T01:15:45Z","timestamp":1790298945449,"version":"4.1.0"},"reference-count":135,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Glycogen storage disorders (GSDs) are a group of inherited metabolic disorders characterized by defects in enzymes involved in glycogen metabolism. Deficiencies in enzymes responsible for glycogen breakdown and synthesis can impair mitochondrial function. For instance, in GSD type II (Pompe disease), acid alpha-glucosidase deficiency leads to lysosomal glycogen accumulation, which secondarily impacts mitochondrial function through dysfunctional mitophagy, which disrupts mitochondrial quality control, generating oxidative stress. In GSD type III (Cori disease), the lack of the debranching enzyme causes glycogen accumulation and affects mitochondrial dynamics and biogenesis by disrupting the integrity of muscle fibers. Malfunctional glycogen metabolism can disrupt various cascades, thus causing mitochondrial and cell metabolic dysfunction through various mechanisms. These dysfunctions include altered mitochondrial morphology, impaired oxidative phosphorylation, increased production of reactive oxygen species (ROS), and defective mitophagy. The oxidative burden typical of GSDs compromises mitochondrial integrity and exacerbates the metabolic derangements observed in GSDs. The intertwining of mitochondrial dysfunction and GSDs underscores the complexity of these disorders and has significant clinical implications. GSD patients often present with multisystem manifestations, including hepatomegaly, hypoglycemia, and muscle weakness, which can be exacerbated by mitochondrial impairment. Moreover, mitochondrial dysfunction may contribute to the progression of GSD-related complications, such as cardiomyopathy and neurocognitive deficits. Targeting mitochondrial dysfunction thus represents a promising therapeutic avenue in GSDs. Potential strategies include antioxidants to mitigate oxidative stress, compounds that enhance mitochondrial biogenesis, and gene therapy to correct the underlying mitochondrial enzyme deficiencies. Mitochondrial dysfunction plays a critical role in the pathophysiology of GSDs. Recognizing and addressing this aspect can lead to more comprehensive and effective treatments, improving the quality of life of GSD patients. This review aims to elaborate on the intricate relationship between mitochondrial dysfunction and various types of GSDs. The review presents challenges and treatment options for several GSDs.<\/jats:p>","DOI":"10.3390\/biom14091096","type":"journal-article","created":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T03:45:21Z","timestamp":1725248721000},"page":"1096","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Mitochondrial Dysfunction in Glycogen Storage Disorders (GSDs)"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7537-8070","authenticated-orcid":false,"given":"Kumudesh","family":"Mishra","sequence":"first","affiliation":[{"name":"Department of Neurology, The Agnes Ginges Center for Human Neurogenetics, Hadassah-Hebrew University Medical Center, Jerusalem 9112001, Israel"},{"name":"Faculty of Medicine, Hebrew University of Jerusalem, Ein Kerem, Jerusalem 9112102, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7435-6454","authenticated-orcid":false,"given":"Or","family":"Kakhlon","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Agnes Ginges Center for Human Neurogenetics, Hadassah-Hebrew University Medical Center, Jerusalem 9112001, Israel"},{"name":"Faculty of Medicine, Hebrew University of Jerusalem, Ein Kerem, Jerusalem 9112102, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,9,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.3748\/wjg.v29.i25.3932","article-title":"Glycogen storage diseases: An update","volume":"29","year":"2023","journal-title":"World J. Gastroenterol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"474","DOI":"10.21037\/atm.2018.10.59","article-title":"Glycogen metabolism and glycogen storage disorders","volume":"6","author":"Kanungo","year":"2018","journal-title":"Ann. Transl. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s13023-022-02387-6","article-title":"Glycogen storage diseases with liver involvement: A literature review of GSD type 0, IV, VI, IX and XI","volume":"17","author":"Massese","year":"2022","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"de Marchi, R., Nalin, T., Sperb-Ludwig, F., Pinheiro, F.C., Schwartz, I.V.D., and Steiner, C.E. (2023). Glycogen Storage Disease: Expert Opinion on Clinical Diagnosis Revisited after Molecular Testing. Genes, 14.","DOI":"10.3390\/genes14122219"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/joim.13064","article-title":"Mitochondrial diseases in adults","volume":"287","author":"Maresca","year":"2020","journal-title":"J. Intern. Med."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Nsiah-Sefaa, A., and McKenzie, M. (2016). Combined defects in oxidative phosphorylation and fatty acid \u03b2-oxidation in mitochondrial disease. Biosci. Rep., 36.","DOI":"10.1042\/BSR20150295"},{"key":"ref_7","first-page":"e160020","article-title":"Mechanisms by which metabolic reprogramming in GSD1 liver generates a favorable tumorigenic environment","volume":"4","author":"Gjorgjieva","year":"2019","journal-title":"J. Inborn Errors Metab. Screen."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e13573","DOI":"10.1111\/cpr.13573","article-title":"Mitochondrial dysfunction is associated with hypertrophic cardiomyopathy in Pompe disease-specific induced pluripotent stem cell-derived cardiomyocytes","volume":"57","author":"Huang","year":"2024","journal-title":"Cell Prolif."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.bbadis.2016.11.010","article-title":"Mitochondrial dysfunction and oxidative stress in metabolic disorders\u2014A step towards mitochondria based therapeutic strategies","volume":"1863","author":"Bhatti","year":"2017","journal-title":"Biochim. Biophys. Acta (BBA)-Mol. Basis Dis."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Stepien, K.M., Roncaroli, F., Turton, N., Hendriksz, C.J., Roberts, M., Heaton, R.A., and Hargreaves, I. (2020). Mechanisms of mitochondrial dysfunction in lysosomal storage disorders: A review. J. Clin. Med., 9.","DOI":"10.3390\/jcm9082596"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s10545-016-9932-2","article-title":"Glycogen storage disease type III: Diagnosis, genotype, management, clinical course and outcome","volume":"39","author":"Sentner","year":"2016","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Farah, B.L., Sinha, R.A., Wu, Y., Singh, B.K., Lim, A., Hirayama, M., Landau, D.J., Bay, B.H., Koeberl, D.D., and Yen, P.M. (2017). Hepatic mitochondrial dysfunction is a feature of glycogen storage disease type Ia (GSDIa). Sci. Rep., 7.","DOI":"10.1038\/srep44408"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Mishra, K., Sweetat, S., Baraghithy, S., Sprecher, U., Marisat, M., Bastu, S., Glickstein, H., Tam, J., Rosenmann, H., and Weil, M. (2024). The Autophagic Activator GHF-201 Can Alleviate Pathology in a Mouse Model and in Patient Fibroblasts of Type III Glycogenosis. Biomolecules, 14.","DOI":"10.20944\/preprints202406.0334.v1"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"101648","DOI":"10.1016\/j.molmet.2022.101648","article-title":"Low aerobic capacity in McArdle disease: A role for mitochondrial network impairment?","volume":"66","author":"Andreu","year":"2022","journal-title":"Mol. Metab."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/jmd2.12082","article-title":"Hepatic glycogen synthase (GYS2) deficiency: Seven novel patients and seven novel variants","volume":"53","author":"Kamenets","year":"2020","journal-title":"JIMD Rep."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1515\/jpem-2016-0317","article-title":"The variable clinical phenotype of three patients with hepatic glycogen synthase deficiency","volume":"30","author":"Kasapkara","year":"2017","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.nmd.2022.03.008","article-title":"A new phenotype of muscle glycogen synthase deficiency (GSD0B) characterized by an adult onset myopathy without cardiomyopathy","volume":"32","author":"Musumeci","year":"2022","journal-title":"Neuromuscul. Disord."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa066691","article-title":"Cardiomyopathy and exercise intolerance in muscle glycogen storage disease 0","volume":"357","author":"Kollberg","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1067\/mpd.2000.105232","article-title":"Neutropenia, neutrophil dysfunction, and inflammatory bowel disease in glycogen storage disease type Ib: Results of the European Study on Glycogen Storage Disease type I","volume":"137","author":"Visser","year":"2000","journal-title":"J. Pediatr."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Veiga-da-Cunha, M., Wortmann, S.B., Gr\u00fcnert, S.C., and Van Schaftingen, E. (2023). Treatment of the neutropenia associated with GSD1b and G6PC3 deficiency with SGLT2 inhibitors. Diagnostics, 13.","DOI":"10.3390\/diagnostics13101803"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Meena, N.K., and Raben, N. (2020). Pompe disease: New developments in an old lysosomal storage disorder. Biomolecules, 10.","DOI":"10.3390\/biom10091339"},{"key":"ref_22","first-page":"237","article-title":"Variable clinical presentation of glycogen storage disease type IV: From severe hepatosplenomegaly to cardiac insufficiency. Some discrepancies in genetic and biochemical abnormalities","volume":"14","author":"Truszkowska","year":"2018","journal-title":"Arch. Med. Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e14554","DOI":"10.15252\/emmm.202114554","article-title":"Alleviation of a polyglucosan storage disorder by enhancement of autophagic glycogen catabolism","volume":"13","author":"Kakhlon","year":"2021","journal-title":"EMBO Mol. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"107525","DOI":"10.1016\/j.ymgme.2023.107525","article-title":"Diagnosis and management of glycogen storage disease type IV, including adult polyglucosan body disease: A clinical practice resource","volume":"138","author":"Koch","year":"2023","journal-title":"Mol. Genet. Metab."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Da Silva, J.D., Pereira, \u00c2., Soares, A.R., Guimas, A., Rocha, S., Cardoso, M., Garrido, C., Soares, C.A., Nunes, I.S., and Fortuna, A.M. (2023). Diagnostic accuracy and the first genotype\u2013phenotype correlation in glycogen storage disease type V. Pediatr. Res., 1\u20137.","DOI":"10.1038\/s41390-023-02943-1"},{"key":"ref_26","unstructured":"Labrador, E., and Weinstein, D.A. (2019). Glycogen storage disease type VI. GeneReviews\u00ae [Internet], University of Washington."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00431-019-03499-1","article-title":"Glycogen storage disease type VI: Clinical course and molecular background","volume":"179","author":"Aeppli","year":"2020","journal-title":"Eur. J. Pediatr."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.nmd.2011.10.022","article-title":"Clinical features and new molecular findings in muscle phosphofructokinase deficiency (GSD type VII)","volume":"22","author":"Musumeci","year":"2012","journal-title":"Neuromuscular Disord."},{"key":"ref_29","first-page":"96","article-title":"Progress and problems in muscle glycogenoses","volume":"30","author":"DiMauro","year":"2011","journal-title":"Acta Myol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ymgme.2020.10.004","article-title":"Benign or not benign? Deep phenotyping of liver Glycogen Storage Disease IX","volume":"131","author":"Fernandes","year":"2020","journal-title":"Mol. Genet. Metab."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ymgme.2014.09.005","article-title":"The natural history of glycogen storage disease types VI and IX: Long-term outcome from the largest metabolic center in Canada","volume":"113","author":"Roscher","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/s41436-018-0364-2","article-title":"Diagnosis and management of glycogen storage diseases type VI and IX: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)","volume":"21","author":"Kishnani","year":"2019","journal-title":"Genet. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/8904_2017_8","article-title":"Clinical and molecular variability in patients with PHKA2 variants and liver phosphorylase b kinase deficiency","volume":"37","author":"Bali","year":"2017","journal-title":"JIMD Rep."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"R131","DOI":"10.1530\/JOE-18-0120","article-title":"Biochemical and clinical aspects of glycogen storage diseases","volume":"238","author":"Ellingwood","year":"2018","journal-title":"J. Endocrinol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/jmd2.12220","article-title":"Human d-lactate dehydrogenase deficiency by LDHD mutation in a patient with neurological manifestations and mitochondrial complex IV deficiency","volume":"60","author":"Kwong","year":"2021","journal-title":"JIMD Rep."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Serrano-Lorenzo, P., Rabasa, M., Esteban, J., Hidalgo Mayoral, I., Dom\u00ednguez-Gonz\u00e1lez, C., Blanco-Echevarr\u00eda, A., Garrido-Moraga, R., Lucia, A., Bl\u00e1zquez, A., and Rubio, J.C. (2022). Clinical, biochemical, and molecular characterization of two families with novel mutations in the LDHA gene (GSD XI). Genes, 13.","DOI":"10.3390\/genes13101835"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"6638","DOI":"10.1038\/s41467-023-42456-3","article-title":"Lactate dehydrogenase D is a general dehydrogenase for D-2-hydroxyacids and is associated with D-lactic acidosis","volume":"14","author":"Jin","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Mamoune, A., Bahuau, M., Hamel, Y., Serre, V., Pelosi, M., Habarou, F., Nguyen Morel, M.-A., Boisson, B., Vergnaud, S., and Viou, M.T. (2014). A thermolabile aldolase A mutant causes fever-induced recurrent rhabdomyolysis without hemolytic anemia. PLoS Genet., 10.","DOI":"10.1371\/journal.pgen.1004711"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"100730","DOI":"10.1016\/j.ymgmr.2021.100730","article-title":"Aldolase A deficiency: Report of new cases and literature review","volume":"27","author":"Papadopoulos","year":"2021","journal-title":"Mol. Genet. Metab. Rep."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/jmd2.12070","article-title":"The need for biochemical testing in beta-enolase deficiency in the genomic era","volume":"50","author":"Wigley","year":"2019","journal-title":"JIMD Rep."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/jmd2.12232","article-title":"Energy metabolism during exercise in patients with \u03b2-enolase deficiency (GSDXIII)","volume":"61","author":"Buch","year":"2021","journal-title":"JIMD Rep."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ana.24284","article-title":"A new muscle glycogen storage disease associated with glycogenin-1 deficiency","volume":"76","author":"Malfatti","year":"2014","journal-title":"Ann. Neurol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1210\/clinem\/dgz075","article-title":"Glycogenin is dispensable for glycogen synthesis in human muscle, and glycogenin deficiency causes polyglucosan storage","volume":"105","author":"Visuttijai","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ymgme.2020.08.003","article-title":"Phosphoglucomutase-1 deficiency: Early presentation, metabolic management and detection in neonatal blood spots","volume":"131","author":"Conte","year":"2020","journal-title":"Mol. Genet. Metab."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/jimd.12286","article-title":"International consensus guidelines for phosphoglucomutase 1 deficiency (PGM1-CDG): Diagnosis, follow-up, and management","volume":"44","author":"Altassan","year":"2021","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ymgme.2011.11.200","article-title":"Fanconi\u2013Bickel syndrome: GLUT2 mutations associated with a mild phenotype","volume":"105","author":"Schwab","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Sharari, S., Abou-Alloul, M., Hussain, K., and Ahmad Khan, F. (2020). Fanconi\u2013bickel syndrome: A review of the mechanisms that lead to dysglycaemia. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21176286"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"132","DOI":"10.5582\/irdr.2017.01020","article-title":"A novel PGK1 mutation associated with neurological dysfunction and the absence of episodes of hemolytic anemia or myoglobinuria","volume":"6","author":"Matsumaru","year":"2017","journal-title":"Intractable Rare Dis. Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/jimd.12087","article-title":"Phosphoglycerate kinase deficiency: A nationwide multicenter retrospective study","volume":"42","author":"Nadjar","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1161\/CIRCRESAHA.116.305420","article-title":"Maintaining ancient organelles: Mitochondrial biogenesis and maturation","volume":"116","author":"Vega","year":"2015","journal-title":"Circ. Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"G205","DOI":"10.1152\/ajpgi.00270.2015","article-title":"Defect of mitochondrial respiratory chain is a mechanism of ROS overproduction in a rat model of alcoholic liver disease: Role of zinc deficiency","volume":"310","author":"Sun","year":"2016","journal-title":"Am. J. Physiol.-Gastrointest. Liver Physiol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1136\/jmedgenet-2012-101159","article-title":"Complex I deficiency: Clinical features, biochemistry and molecular genetics","volume":"49","author":"Fassone","year":"2012","journal-title":"J. Med. Genet."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.bbabio.2016.02.012","article-title":"Mitochondrial complex I-linked disease","volume":"1857","author":"Rodenburg","year":"2016","journal-title":"Biochim. Biophys. Acta (BBA)-Bioenerg."},{"key":"ref_54","first-page":"78","article-title":"Mitochondrial dysfunction in children with hepatic forms of glycogen storage disease","volume":"69","author":"Kurbatova","year":"2014","journal-title":"Ann. Russ. Acad. Med. Sci."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.nmd.2010.06.011","article-title":"Investigating glycogenosis type III patients with multi-parametric functional NMR imaging and spectroscopy","volume":"20","author":"Wary","year":"2010","journal-title":"Neuromuscular Disord."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ymgme.2013.02.008","article-title":"Exercise intolerance in glycogen storage disease type III: Weakness or energy deficiency?","volume":"109","author":"Preisler","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13023-022-02184-1","article-title":"Aerobic capacity and skeletal muscle characteristics in glycogen storage disease IIIa: An observational study","volume":"17","author":"Hennis","year":"2022","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Hannibal, L., Theimer, J., Wingert, V., Klotz, K., Bierschenk, I., Nitschke, R., Spiekerkoetter, U., and Gruenert, S.C. (2020). Metabolic profiling in human fibroblasts enables subtype clustering in glycogen storage disease. Front. Endocrinol., 11.","DOI":"10.3389\/fendo.2020.579981"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s10545-018-0149-4","article-title":"Insulin-resistance in glycogen storage disease type Ia: Linking carbohydrates and mitochondria?","volume":"41","author":"Rossi","year":"2018","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/S1096-7192(22)00211-6","article-title":"The use of alanine, free carnitine and IGFBP-1 as potential biomarkers for glycogen storage disease type I","volume":"136","author":"Saavedra","year":"2022","journal-title":"Mol. Genet. Metab."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12263-023-00729-y","article-title":"Mitochondrial reprogramming in peripheral blood mononuclear cells of patients with glycogen storage disease type Ia","volume":"18","author":"Rossi","year":"2023","journal-title":"Genes Nutr."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Ramanathan, R., Ali, A.H., and Ibdah, J.A. (2022). Mitochondrial dysfunction plays central role in nonalcoholic fatty liver disease. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23137280"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.tem.2015.07.006","article-title":"Ceramides\u2013lipotoxic inducers of metabolic disorders","volume":"26","author":"Chaurasia","year":"2015","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jconrel.2015.03.036","article-title":"Mitochondrial biology, targets, and drug delivery","volume":"207","author":"Milane","year":"2015","journal-title":"J. Control. Release"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/s41419-023-06202-3","article-title":"Inhibition of mitochondrial fission activates glycogen synthesis to support cell survival in colon cancer","volume":"14","author":"Hasani","year":"2023","journal-title":"Cell Death Dis."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01.gim.0000218152.87434.f3","article-title":"Pompe disease diagnosis and management guideline","volume":"8","author":"Kishnani","year":"2006","journal-title":"Genet. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1161\/CIRCULATIONAHA.121.053575","article-title":"Altered cardiac energetics and mitochondrial dysfunction in hypertrophic cardiomyopathy","volume":"144","author":"Ranjbarvaziri","year":"2021","journal-title":"Circulation"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1161\/CIRCRESAHA.121.318241","article-title":"Cardiac energy metabolism in heart failure","volume":"128","author":"Lopaschuk","year":"2021","journal-title":"Circ. Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1093\/hmg\/ddr424","article-title":"Human Pompe disease-induced pluripotent stem cells for pathogenesis modeling, drug testing and disease marker identification","volume":"20","author":"Huang","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1080\/15548627.2015.1009779","article-title":"Defects in calcium homeostasis and mitochondria can be reversed in Pompe disease","volume":"11","author":"Lim","year":"2015","journal-title":"Autophagy"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41388-023-02907-z","article-title":"ROS production by mitochondria: Function or dysfunction?","volume":"43","author":"Palma","year":"2024","journal-title":"Oncogene"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Napolitano, G., Fasciolo, G., and Venditti, P. (2021). Mitochondrial management of reactive oxygen species. Antioxidants, 10.","DOI":"10.3390\/antiox10111824"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.freeradbiomed.2021.02.043","article-title":"Mitochondrial ROS and mitochondria-targeted antioxidants in the aged heart","volume":"167","author":"Kaludercic","year":"2021","journal-title":"Free. Radic. Biol. Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.freeradbiomed.2021.02.041","article-title":"Mitochondrial redox and TCA cycle metabolite signaling in the heart","volume":"166","author":"Vujic","year":"2021","journal-title":"Free. Radic. Biol. Med."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1038\/s41467-019-09566-3","article-title":"Mitochondria-specific drug release and reactive oxygen species burst induced by polyprodrug nanoreactors can enhance chemotherapy","volume":"10","author":"Zhang","year":"2019","journal-title":"Nat Commun."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Kim, J., and Bai, H. (2022). Peroxisomal stress response and inter-organelle communication in cellular homeostasis and aging. Antioxidants, 11.","DOI":"10.3390\/antiox11020192"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0026-0495(00)80077-3","article-title":"What is oxidative stress?","volume":"49","author":"Betteridge","year":"2000","journal-title":"Metabolism"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.bbadis.2013.05.017","article-title":"Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistance","volume":"1842","author":"Lee","year":"2014","journal-title":"Biochim. Biophys. Acta (BBA)-Mol. Basis Dis."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Prasun, P. (2020). Mitochondrial dysfunction in metabolic syndrome. Biochim. Biophys. Acta (BBA)-Mol. Basis Dis., 1866.","DOI":"10.1016\/j.bbadis.2020.165838"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1038\/s41588-018-0264-z","article-title":"Mitochondrial genetic medicine","volume":"50","author":"Wallace","year":"2018","journal-title":"Nat. Genet."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Urbani, A., and Babu, M. (2019). Mitochondrial Genetics. Mitochondria in Health and in Sickness, Springer.","DOI":"10.1007\/978-981-13-8367-0"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Abu Shelbayeh, O., Arroum, T., Morris, S., and Busch, K.B. (2023). PGC-1\u03b1 is a master regulator of mitochondrial lifecycle and ROS stress response. Antioxidants, 12.","DOI":"10.3390\/antiox12051075"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.metabol.2017.11.001","article-title":"Coordination of mitochondrial biogenesis by PGC-1\u03b1 in human skeletal muscle: A re-evaluation","volume":"79","author":"Islam","year":"2018","journal-title":"Metabolism"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1444.e1","DOI":"10.1016\/j.cell.2022.03.027","article-title":"SnapShot: Regulation and biology of PGC-1\u03b1","volume":"185","author":"Jannig","year":"2022","journal-title":"Cell"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"E751","DOI":"10.1152\/ajpendo.00745.2009","article-title":"AMPK and SIRT1: A long-standing partnership?","volume":"298","author":"Ruderman","year":"2010","journal-title":"Am. J. Physiol.-Endocrinol. Metab."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.cmet.2015.05.005","article-title":"Beyond energy homeostasis: The expanding role of AMP-activated protein kinase in regulating metabolism","volume":"21","author":"Carling","year":"2015","journal-title":"Cell Metab."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Yoboue, E.D., and Devin, A. (2012). Reactive oxygen species-mediated control of mitochondrial biogenesis. Int J Cell Biol., 2012.","DOI":"10.1155\/2012\/403870"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1007\/s10545-018-0192-1","article-title":"Sirtuin signaling controls mitochondrial function in glycogen storage disease type Ia","volume":"41","author":"Cho","year":"2018","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1002\/jcp.30819","article-title":"Expanding the view of the molecular mechanisms of autophagy pathway","volume":"237","author":"Majeed","year":"2022","journal-title":"J. Cell. Physiol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/15548627.2017.1378838","article-title":"Autophagy pathway: Cellular and molecular mechanisms","volume":"14","author":"Yu","year":"2018","journal-title":"Autophagy"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.molmed.2019.10.009","article-title":"Mitochondria\u2013lysosome crosstalk: From physiology to neurodegeneration","volume":"26","author":"Deus","year":"2020","journal-title":"Trends Mol. Med."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/jnc.14471","article-title":"Mitochondria, lysosomes, and dysfunction: Their meaning in neurodegeneration","volume":"147","author":"Audano","year":"2018","journal-title":"J. Neurochem."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Narendra, D.P., Jin, S.M., Tanaka, A., Suen, D.-F., Gautier, C.A., Shen, J., Cookson, M.R., and Youle, R.J. (2010). PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol., 8.","DOI":"10.1371\/journal.pbio.1000298"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"e2501","DOI":"10.1038\/cddis.2016.396","article-title":"PINK1-dependent phosphorylation of PINK1 and Parkin is essential for mitochondrial quality control","volume":"7","author":"Zhuang","year":"2016","journal-title":"Cell Death Dis."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Zheng, H., Zhu, H., Liu, X., Huang, X., Huang, A., and Huang, Y. (2021). Mitophagy in diabetic cardiomyopathy: Roles and mechanisms. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.750382"},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Nakamura, K., Miyoshi, T., Yoshida, M., Akagi, S., Saito, Y., Ejiri, K., Matsuo, N., Ichikawa, K., Iwasaki, K., and Naito, T. (2022). Pathophysiology and treatment of diabetic cardiomyopathy and heart failure in patients with diabetes mellitus. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23073587"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2015.10.008","article-title":"Induction of autophagy improves hepatic lipid metabolism in glucose-6-phosphatase deficiency","volume":"64","author":"Farah","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Cho, J.-H., Kim, G.-Y., Pan, C.-J., Anduaga, J., Choi, E.-J., Mansfield, B.C., and Chou, J.Y. (2017). Downregulation of SIRT1 signaling underlies hepatic autophagy impairment in glycogen storage disease type Ia. PLoS Genet., 13.","DOI":"10.1371\/journal.pgen.1006819"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ymgme.2019.11.005","article-title":"Links between autophagy and disorders of glycogen metabolism\u2013perspectives on pathogenesis and possible treatments","volume":"129","author":"Farah","year":"2020","journal-title":"Mol. Genet. Metab."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.neurol.2021.06.006","article-title":"Lafora disease: Current biology and therapeutic approaches","volume":"178","author":"Mitra","year":"2022","journal-title":"Rev. Neurol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1111\/febs.14468","article-title":"Degradation of altered mitochondria by autophagy is impaired in Lafora disease","volume":"285","author":"Lahuerta","year":"2018","journal-title":"FEBS J."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"e00292","DOI":"10.1016\/j.neurot.2023.10.002","article-title":"Mitochondrial dysfunction in neurodegenerative disorders","volume":"21","author":"Klemmensen","year":"2024","journal-title":"Neurotherapeutics"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s13238-014-0089-1","article-title":"Mitochondria-mediated apoptosis in mammals","volume":"5","author":"Xiong","year":"2014","journal-title":"Protein Cell"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.bbrc.2015.01.137","article-title":"Calcium and mitochondria in the regulation of cell death","volume":"460","author":"Orrenius","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/978-94-007-2869-1_7","article-title":"The mitochondrial pathways of apoptosis","volume":"942","author":"Estaquier","year":"2012","journal-title":"Adv Exp Med Biol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ymgme.2009.04.003","article-title":"Activation of glycolysis and apoptosis in glycogen storage disease type Ia","volume":"97","author":"Sun","year":"2009","journal-title":"Mol. Genet. Metab."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s13311-018-00684-2","article-title":"Myopathies related to glycogen metabolism disorders","volume":"15","author":"Tarnopolsky","year":"2018","journal-title":"Neurotherapeutics"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.nmd.2019.09.011","article-title":"Clinical features of Pompe disease with motor neuronopathy","volume":"29","author":"Tsai","year":"2019","journal-title":"Neuromuscular Disord."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/BF03345235","article-title":"Metabolic response to exercise","volume":"26","author":"Lucidi","year":"2003","journal-title":"J. Endocrinol. Investig."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1249\/MSS.0000000000002915","article-title":"Long-Term Exercise Intervention in Patients with McArdle Disease: Clinical and Aerobic Fitness Benefits","volume":"54","author":"Santalla","year":"2022","journal-title":"Med. Sci. Sports Exerc."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1249\/MSS.0000000000000458","article-title":"Cardiorespiratory fitness, physical activity, and quality of life in patients with McArdle disease","volume":"47","author":"Santalla","year":"2015","journal-title":"Med. Sci. Sports Exerc."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1186\/s13023-020-01562-x","article-title":"Data from the European registry for patients with McArdle disease and other muscle glycogenoses (EUROMAC)","volume":"15","author":"Scalco","year":"2020","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12864-017-4188-2","article-title":"Genotypic and phenotypic features of all Spanish patients with McArdle disease: A 2016 update","volume":"18","author":"Santalla","year":"2017","journal-title":"BMC Genom."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1002\/jimd.12438","article-title":"Phenotype and genotype of 197 British patients with McArdle disease: An observational single-centre study","volume":"44","author":"Pizzamiglio","year":"2021","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_115","first-page":"764","article-title":"Impairment of muscle mitochondrial oxidative metabolism in McArdle\u2019s disease","volume":"19","author":"Argov","year":"1996","journal-title":"Muscle Nerve Off. J. Am. Assoc. Electrodiagn. Med."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1056\/NEJMoa0900661","article-title":"Glycogenin-1 deficiency and inactivated priming of glycogen synthesis","volume":"362","author":"Moslemi","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1038\/gim.2014.128","article-title":"Diagnosis and management of glycogen storage disease type I: A practice guideline of the American College of Medical Genetics and Genomics","volume":"16","author":"Kishnani","year":"2014","journal-title":"Genet. Med."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/s41572-023-00456-z","article-title":"Glycogen storage diseases","volume":"9","author":"Hannah","year":"2023","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Keutzer, J.M. (2020). Establishing Pompe disease newborn screening: The role of industry. Int. J. Neonatal Screen., 6.","DOI":"10.3390\/ijns6030055"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3233\/JAD-2006-10110","article-title":"Mitochondrial dysfunction, oxidative stress and neurodegeneration","volume":"10","author":"Mancuso","year":"2006","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s10545-010-9081-y","article-title":"Biochemical diagnosis of mitochondrial disorders","volume":"34","author":"Rodenburg","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.mito.2011.07.006","article-title":"Optimization of respiratory chain enzymatic assays in muscle for the diagnosis of mitochondrial disorders","volume":"11","author":"Spinazzi","year":"2011","journal-title":"Mitochondrion"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/nprot.2012.058","article-title":"Assessment of mitochondrial respiratory chain enzymatic activities on tissues and cultured cells","volume":"7","author":"Spinazzi","year":"2012","journal-title":"Nat. Protoc."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.mito.2009.05.001","article-title":"Development and implementation of standardized respiratory chain spectrophotometric assays for clinical diagnosis","volume":"9","author":"Medja","year":"2009","journal-title":"Mitochondrion"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/mus.10381","article-title":"Morphological changes in muscle tissue of patients with infantile Pompe\u2019s disease receiving enzyme replacement therapy","volume":"27","author":"Winkel","year":"2003","journal-title":"Muscle Nerve Off. J. Am. Assoc. Electrodiagn. Med."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/jimd.12654","article-title":"Gene therapy for glycogen storage diseases","volume":"47","author":"Koeberl","year":"2024","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1089\/hum.2019.102","article-title":"Challenges of gene therapy for the treatment of glycogen storage diseases type I and type III","volume":"30","author":"Jauze","year":"2019","journal-title":"Hum. Gene Ther."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1093\/hmg\/ddz133","article-title":"Gene therapy for glycogen storage diseases","volume":"28","author":"Kishnani","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ymgme.2018.02.013","article-title":"N-acetylcysteine and vitamin E rescue animal longevity and cellular oxidative stress in pre-clinical models of mitochondrial complex I disease","volume":"123","author":"Polyak","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ymgme.2017.09.009","article-title":"Therapies for mitochondrial diseases and current clinical trials","volume":"122","author":"Zarante","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ymgme.2022.06.001","article-title":"Nutritional co-therapy with 1, 3-butanediol and multi-ingredient antioxidants enhances autophagic clearance in Pompe disease","volume":"137","author":"Nilsson","year":"2022","journal-title":"Mol. Genet. Metab."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.coph.2021.11.010","article-title":"The molecular link between oxidative stress, insulin resistance, and type 2 diabetes: A target for new therapies against cardiovascular diseases","volume":"62","author":"Andreadi","year":"2022","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s13023-020-01503-8","article-title":"Improved inflammatory bowel disease, wound healing and normal oxidative burst under treatment with empagliflozin in glycogen storage disease type Ib","volume":"15","author":"Elling","year":"2020","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_134","first-page":"1033","article-title":"Treating neutropenia and neutrophil dysfunction in glycogen storage disease type Ib with an SGLT2 inhibitor","volume":"136","author":"Wortmann","year":"2020","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Maiorana, A., Tagliaferri, F., and Dionisi-Vici, C. (2023). Current understanding on pathogenesis and effective treatment of glycogen storage disease type Ib with empagliflozin: New insights coming from diabetes for its potential implications in other metabolic disorders. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1145111"}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/14\/9\/1096\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:46:41Z","timestamp":1760111201000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/14\/9\/1096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,1]]},"references-count":135,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["biom14091096"],"URL":"https:\/\/doi.org\/10.3390\/biom14091096","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,1]]}}}